Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America: (537722009-001)
The DOI matches its Crossref record.
Abstract
This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged >/=18 years) and adolescents (i.e., persons aged 13--17 years), last published in 2002 and 2004, respectively. It has been prepared by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by clinicians and other health-care providers, HIV-infected patients, and policy makers in the United States. These guidelines address several OIs that occur in the United States and five OIs that might be acquired during international travel. Topic areas covered for each OI include epidemiology, clinical manifestations, diagnosis, prevention of exposure; prevention of disease by chemoprophylaxis and vaccination; discontinuation of primary prophylaxis after immune reconstitution; treatment of disease; monitoring for adverse effects during treatment; management of treatment failure; prevention of disease recurrence; discontinuation of secondary prophylaxis after immune reconstitution; and special considerations during pregnancy. These guidelines were developed by a panel of specialists from the United States government and academic institutions. For each OI, a small group of specialists with content-matter expertise reviewed the literature for new information since the guidelines were last published; they then proposed revised recommendations at a meeting held at NIH in June 2007. After these presentations and discussion, the revised guidelines were further reviewed by the co-editors; by the Office of AIDS Research, NIH; by specialists at CDC; and by HIVMA of IDSA before final approval and publication. The recommendations are rated by a letter that indicates the strength of the recommendation and a Roman numeral that indicates the quality of evidence supporting the recommendation, so that readers can ascertain how best to apply the recommendations in their practice environments. Major changes in the guidelines include 1) greater emphasis on the importance of antiretroviral therapy for the prevention and treatment of OIs, especially those OIs for which no specific therapy exists; 2) information regarding the diagnosis and management of immune reconstitution inflammatory syndromes; 3) information regarding the use of interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis (TB) infection; 4) updated information concerning drug interactions that affect the use of rifamycin drugs for prevention and treatment of TB; 5) the addition of a section on hepatitis B virus infection; and 6) the addition of malaria to the list of OIs that might be acquired during international travel. This report includes eleven tables pertinent to the prevention and treatment of OIs, a figure that pertains to the diagnois of tuberculosis, a figure that describes immunization recommendations, and an appendix that summarizes recommendations for prevention of exposure to opportunistic pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa
Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S., & Gordon, M. A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61752-2 · Cited by 1,014
Checkley, W., White, A. C., Jaganath, D., Arrowood, M. J., Chalmers, R. M., Chen, X.-M., Fayer, R., Griffiths, J. K., Guerrant, R. L., Hedstrom, L., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70772-8 · Cited by 987
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Self-citationWang, H., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Abraha, H. N., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31833-0 · Cited by 801
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Cancer Burden in the HIV-Infected Population in the United States
Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., Bhatia, K., Uldrick, T. S., Yarchoan, R., Goedert, J. J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr076 · Cited by 778
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J., MacDonald, J. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw360 · Cited by 622
Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention
Elmore, S. A., Jones, J. L., Conrad, P. A., Patton, S., Lindsay, D. S., & Dubey, J. P. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.01.009 · Cited by 516
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504
Risk Factors for Toxoplasma gondii Infection in the United States
Jones, J. L., Dargelas, V., Roberts, J., Press, C., Remington, J. S., & Montoya, J. G. (2009) · Clinical Infectious Diseases · doi:10.1086/605433 · Cited by 490
Smith, R. A., Manassaram-Baptiste, D., Brooks, D., Cokkinides, V., Doroshenk, M., Saslow, D., Wender, R. C., & Brawley, O. W. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21212 · Cited by 478
Limper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Stern, A., Green, H., Paul, M., Vidal, L., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005590.pub3 · Cited by 452
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
Colonization by Pneumocystis jirovecii and Its Role in Disease
Morris, A., & Norris, K. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-12 · Cited by 429
Smith, R. A., Brooks, D., Cokkinides, V., Saslow, D., & Brawley, O. W. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21174 · Cited by 422
Clofazimine: current status and future prospects
Cholo, M. C., Steel, H. C., Fourie, P. B., Germishuizen, W. A., & Anderson, R. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr444 · Cited by 351
Leishmaniasis in immunosuppressed individuals
van Griensven, J., Carrillo, E., López-Vélez, R., Lynen, L., & Moreno, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12556 · Cited by 348
Cohort Profile: The Swiss HIV Cohort Study
Study, T. S. H. C., Schoeni-Affolter, F., Ledergerber, B., Rickenbach, M., Rudin, C., Gunthard, H. F., Telenti, A., Furrer, H., Yerly, S., & Francioli, P. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp321 · Cited by 346
AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study
Buchacz, K., Baker, R. K., Palella, F. J., Chmiel, J. S., Lichtenstein, K. A., Novak, R. M., Wood, K. C., & Brooks, J. T. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3967 · Cited by 332
Self-citationCumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D'Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2768 · Cited by 328
Self-citationBoulware, D. R., Rolfes, M. A., Rajasingham, R., von Hohenberg, M., Qin, Z., Taseera, K., Schutz, C., Kwizera, R., Butler, E. K., Meintjes, G., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2001.130906 · Cited by 321
Torok, M. E., Yen, N. T. B., Chau, T. T. H., Mai, N. T. H., Phu, N. H., Mai, P. P., Dung, N. T., Chau, N. V. V., Bang, N. D., Tien, N. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir230 · Cited by 312
Haddow, L. J., Colebunders, R., Meintjes, G., Lawn, S. D., Elliott, J. H., Manabe, Y. C., Bohjanen, P. R., Sungkanuparph, S., Easterbrook, P. J., French, M. A., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70170-5 · Cited by 302
Meya, D. B., Manabe, Y. C., Castelnuovo, B., Cook, B. A., Elbireer, A. M., Kambugu, A., Kamya, M. R., Bohjanen, P. R., & Boulware, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/655143 · Cited by 296
Adverse reactions to vaccines practice parameter 2012 update
Kelso, J. M., Greenhawt, M. J., Li, J. T., Nicklas, R. A., Bernstein, D. I., Blessing-Moore, J., Cox, L., Khan, D., Lang, D. M., Oppenheimer, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.003 · Cited by 293
The Clinical and Prognostic Importance of Positive Blood Cultures in Adults
Pien, B. C., Sundaram, P., Raoof, N., Costa, S. F., Mirrett, S., Woods, C. W., Reller, L. B., & Weinstein, M. P. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.03.021 · Cited by 293
Chagas Disease in the United States: a Public Health Approach
Bern, C., Messenger, L. A., Whitman, J. D., & Maguire, J. H. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-19 · Cited by 282
Nguyen, C., Barker, B. M., Hoover, S., Nix, D. E., Ampel, N. M., Frelinger, J. A., Orbach, M. J., & Galgiani, J. N. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-13 · Cited by 272
Masur, H., Brooks, J. T., Benson, C. A., Holmes, K. K., Pau, A. K., & Kaplan, J. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu094 · Cited by 269
Self-citationNeglected Parasitic Infections in the United States: Toxoplasmosis
Jones, J. L., Parise, M. E., & Fiore, A. E. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0722 · Cited by 268
Excess Cancers Among HIV-Infected People in the United States
Robbins, H. A., Pfeiffer, R. M., Shiels, M. S., Li, J., Hall, H. I., & Engels, E. A. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju503 · Cited by 262
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis
Elsheikha, H. M., Marra, C. M., & Zhu, X.-Q. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-19 · Cited by 262
III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia
Conde, M. B., Melo, F. A. F. D., Marques, A. M. C., Cardoso, N. C., Pinheiro, V. G. F., Dalcin, P. D. T. R., Machado Junior, A., Lemos, A. C. M., Netto, A. R., Durovni, B., et al. (2009) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132009001000011 · Cited by 261
Is sexual contact a major mode of hepatitis C virus transmission?
Tohme, R. A., & Holmberg, S. D. (2010) · Hepatology · doi:10.1002/hep.23808 · Cited by 248
The Mind Exchange Working Group, Antinori, A., Arendt, G., Grant, I., Letendre, S., Chair, Munoz-Moreno, J. A., Eggers, C., Brew, B., Brouillette, M.-J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis975 · Cited by 208
HIV-Associated Pneumocystis Pneumonia
Huang, L., Cattamanchi, A., Davis, J. L., Boon, S. D., Kovacs, J., Meshnick, S., Miller, R. F., Walzer, P. D., Worodria, W., & Masur, H. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201009-062wr · Cited by 191
Self-citationComprehensive clinical care for men who have sex with men: an integrated approach.
Mayer, K. H., Bekker, L.-G., Stall, R., Grulich, A. E., Colfax, G., & Lama, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60835-6 · Cited by 167
Reducing the risk of pet-associated zoonotic infections
Stull, J. W., Brophy, J., & Weese, J. S. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.141020 · Cited by 177
Visceral Leishmaniasis and HIV Coinfection in East Africa
Diro, E., Lynen, L., Ritmeijer, K., Boelaert, M., Hailu, A., & van Griensven, J. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002869 · Cited by 160
The lifetime medical cost savings from preventing HIV in the United States
Schackman, B. R., Fleishman, J. A., Su, A. E., Berkowitz, B. K., Moore, R. D., Walensky, R. P., Becker, J. E., Voss, C., Paltiel, A. D., Weinstein, M. C., et al. (2015) · Medical Care · doi:10.1097/mlr.0000000000000308 · Cited by 123
Tasaka, S., & Tokuda, H. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0453-0 · Cited by 123
Kuhn, L., Wang, C., Tsai, W.-Y., Wright, T. C., & Denny, L. (2010) · AIDS · doi:10.1097/qad.0b013e32833e163e · Cited by 115
STD screening of HIV-infected MSM in HIV clinics.
Hoover, K. W., Butler, M., Workowski, K., Carpio, F., Follansbee, S., Gratzer, B., Hare, B., Johnston, B., Theodore, J. L., Wohlfeiler, M., et al. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181e50058 · Cited by 105
Self-citationScreening of cervical neoplasia in HIV-infected women in India
Joshi, S., Sankaranarayanan, R., Muwonge, R., Kulkarni, V., Somanathan, T., & Divate, U. (2013) · AIDS · doi:10.1097/qad.0b013e32835b1041 · Cited by 89
Aurelius, E., Franzen-Rohl, E., Glimaker, M., Akre, O., Grillner, L., Jorup-Ronstrom, C., Studahl, M., & the HSV-2 Meningitis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis031 · Cited by 86
Pneumocystis jirovecii pneumonia in kidney transplantation
Goto, N., & Oka, S. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00691.x · Cited by 74
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
Long-term cancer risk among people diagnosed with AIDS during childhood
Simard, E. P., Shiels, M. S., Bhatia, K., & Engels, E. A. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0823 · Cited by 50
Chou, R., Selph, S., Dana, T., Bougatsos, C., Zakher, B., Blazina, I., & Korthuis, P. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00007 · Cited by 46
Viviano, M., DeBeaudrap, P., Tebeu, P.-M., Tsuala Fouogue, J., Vassilakos, P., & Petignat, P. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s103868 · Cited by 42
Metadata
- Authors
- Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H.
- Venue
- PsycEXTRA Dataset
- Published
- 2009
- Volume
- 58
- Issue
- RR-4
- Pages
- 1-207; quiz CE1
- OpenAlex
- W1506224745
- Cited by
- 1,343
- References
- 0
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.